Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ananth Karumanchi

Showing results (1-10 of 367) with videos related to

Pageof 37
Sort By:
Hypertension (Dallas, Tex. : 1979)|April 13, 2016
Angiogenic Factors in Preeclampsia: From Diagnosis to TherapyS Ananth Karumanchi
The Journal of Clinical Investigation|August 1, 2024
Two decades of advances in preeclampsia research: molecular mechanisms and translational studiesS Ananth Karumanchi
Endocrinology|October 19, 2004
Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" questionS Ananth Karumanchi, Yuval Bdolah
American Journal of Obstetrics and Gynecology|February 18, 2022
Discovery of antiangiogenic factors in the pathogenesis of preeclampsiaS Ananth Karumanchi, Towia Libermann
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2008
Flt1, pregnancy, and malaria: evolution of a complex interactionS Ananth Karumanchi, David Haig
Lancet (London, England)|August 31, 2010
A complement to kidney disease: CFHR5 nephropathyS Ananth Karumanchi, Ravi Thadhani
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
Insights Into the Role of Tetrahydrobiopterin Deficiency in the Pathogenesis of Gestational HypertensionVincent Dupont, S Ananth Karumanchi
Nephron. Clinical Practice|June 16, 2007
Pre-eclampsia: clinical manifestations and molecular mechanismsSuzanne Baumwell, S Ananth Karumanchi
Hypertension in Pregnancy|July 29, 2014
Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia"Sarosh Rana, S Ananth Karumanchi
Med (New York, N.Y.)|May 19, 2022
Cell-free plasma RNA signatures as a surrogate biomarker of pregnancy healthYalda Afshar, S Ananth Karumanchi
Pageof 37

Showing results (1-10 of 367) with videos related to

Sort By:
Pageof 37
Hypertension (Dallas, Tex. : 1979)|April 13, 2016
Angiogenic Factors in Preeclampsia: From Diagnosis to TherapyS Ananth Karumanchi
The Journal of Clinical Investigation|August 1, 2024
Two decades of advances in preeclampsia research: molecular mechanisms and translational studiesS Ananth Karumanchi
Endocrinology|October 19, 2004
Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" questionS Ananth Karumanchi, Yuval Bdolah
American Journal of Obstetrics and Gynecology|February 18, 2022
Discovery of antiangiogenic factors in the pathogenesis of preeclampsiaS Ananth Karumanchi, Towia Libermann
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2008
Flt1, pregnancy, and malaria: evolution of a complex interactionS Ananth Karumanchi, David Haig
Lancet (London, England)|August 31, 2010
A complement to kidney disease: CFHR5 nephropathyS Ananth Karumanchi, Ravi Thadhani
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
Insights Into the Role of Tetrahydrobiopterin Deficiency in the Pathogenesis of Gestational HypertensionVincent Dupont, S Ananth Karumanchi
Nephron. Clinical Practice|June 16, 2007
Pre-eclampsia: clinical manifestations and molecular mechanismsSuzanne Baumwell, S Ananth Karumanchi
Hypertension in Pregnancy|July 29, 2014
Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia"Sarosh Rana, S Ananth Karumanchi
Med (New York, N.Y.)|May 19, 2022
Cell-free plasma RNA signatures as a surrogate biomarker of pregnancy healthYalda Afshar, S Ananth Karumanchi
Pageof 37